Subscribe to our Newsletters !!

    Kumar Jeetendra

    Biohazard Waste Safe Disposal – Infection Control & Biosafety

    Biohazard waste is the one that is contaminated with blood or infectious materials and is a source of medical waste. It can be generated in many places inside your facility. In pathology laboratories that analyze human or animal cultures for presence of pathogens, in research labs that develop vaccines or study infection agents, in operating/autopsy

    Reliable Elemental Analysis for Nitrogen, Sulfur, and Chlorine in Biofuels

    First-generation biofuels are already widespread and well established. These are manufactured using processes such as the fermentation of sugar and starch and the hydrocracking of vegetable oils and animal fats. Hydrocracking is a catalytic, hydrogen-based cracking process for producing hydrocarbons of higher molecular weight. Innovative technologies that can extract biofuels from cellulosic biomass and waste

    Sartolab® RF faster higher capacity BT Vacuum Filtration Units introduced by Sartorius

    Sartorius introduced Sartolab® RF|BT 150-1000 vacuum filtration units that the new design has been improved to offer greater capacity and speedier and greater physical stability for a wide range of sample types. Design modifications include: 1.An increase of the membrane surface area to facilitate optimal filtration 2.Replacement of the 0.45 μm cellulose acetate membrane with

    Live Cell Imaging and Analysis system by Sartorius

    The Live-Cell Analysis System of Incucyte is designed to effectively record cellular changes as they occur inside the incubator. Take high-resolution fluorescence images and bright field images, and then record the data in real-time over days, hours or even weeks. From anti-proliferation tests to immune removal of tumour spheroids this system is flexible and allows

    Venair presented at interphex its new updated tubing range and products

    Barcelona, Spain – 7 December 2021 – Life Science Newswire – During October 19-20-21 the Interphex international trade fair was held in New York, an event which stands out for the massive participation of the best companies in the pharmaceutical and biotechnology sector. They take advantage of this great occasion to present their new products

    Alembic Pharmaceuticals receives USFDA Tentative Approval for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg.

    8th December, 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that the Company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Selexipag Tablets, 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1,400 mcg, and 1,600 mcg. The tentatively approved ANDA is therapeutically equivalent

    Cytel and Pulse Infoframe Deploy New Real-World Data Solutions to Transform Rare Disease Research Landscape

    Waltham, MA, December 9, 2021 – A collaboration between Cytel and Pulse Infoframe creates a solution that marks a new direction in research for rare disease. This partnership will support drug development sponsors seeking to implement real-world evidence solutions where the data generated can be used for a range of purposes, from synthetic controls and

    GenNext Technologies Announces its Second Key US Protein Footprinting Patent

    HALF MOON BAY, Calif. – December 9, 2021 – Life Science Newswire – GenNext Technologies, Inc., a growth-stage company providing instrumentation, software, and services, announced today that it has earned a second seminal patent protecting the company’s novel radical dosimetry technology which vastly improves the utility of protein footprinting for the study of biopharmaceutical structure,

    Cipla launches initiative to improve access to nebulisers for acute asthma management in primary health care centres of rural India

    Mumbai, 10th December 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country. With Cipla’s unmatched presence across the care continuum and a wide range of drug-device combinations and treatments, the

    Alembic announces seed round investment in RIGImmune, Inc.

    10th December, 2021, Mumbai: Alembic Pharmaceuticals Limited (Alembic) has announced today that it has made a strategic investment in RIGImmune Inc., a biopharmaceutical research company co-founded by two prominent Yale University professors. RIGImmune Inc. was founded by Dr. Anna Pyle and Dr. Akiko Iwasaki. Dr. Pyle is a Professor of Molecular, Cellular and Developmental Biology

    Aster announces bringing healthcare to the doorsteps through 455 facilities

    Bangalore, 13th December: On Aster DM Healthcare’s 35th Foundation Day, the organisation has announced global growth to 455 facilities and thereby emerging as one of the largest integrated healthcare providers in India and GCC, with 27 hospitals, 126 clinics/labs and 302 pharmacies spread across 7 countries serving around 20 million patients annually. In India, with